Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Background: Nanomaterials have recently been identified for their potential benefits in the areas of medicine and pharmaceuticals. Among these nanomaterials, silver nanoparticles (Ag-NPs) have been widely utilized in the fields of diagnostics, antimicrobials, and catalysis. Objective: To investigate the potential utility of Citrobacter freundii in the synthesis of silver nanoparticles (Ag-NPs), and to determine the antimicrobial activities of the Ag-NPs produced. Methods: Aqueous Ag+ ions were reduced when exposed to C. freundii extract and sunlight, leading to formation of AgNPs. Qualitative microanalysis for the synthesized Ag-NPs was done using UV-vis spectrometry, energy dispersive X-ray analysis (EDX), and scanning and transmission electron microscopy. The hydrodynamic size and stability of the particles were detected using dynamic light scattering (DLS) analysis. The Ag-NPs’ anti-planktonic and anti-biofilm activities against Staphylococcus aureus and Pseudomonas aeruginosa, which are two important skin and wound pathogens, were investigated. The cytotoxicity on human dermal fibroblast cell line was also determined. Results: Ag-NPs were spherical with a size range between 15 to 30 nm. Furthermore, Ag-NPs displayed potent bactericidal activities against both S. aureus and P. aeruginosa and showed noticeable anti-biofilm activity against S. aureus biofilms. Ag-NPs induced minor cytotoxic effects on human cells as indicated by a reduction of cell viability, a disruption of plasma membrane integrity, and apoptosis induction. Conclusion: Ag-NPs generated in this study might be a future potential alternative to be used as antimicrobial agents in pharmaceutical applications for wound and skin related infections.

Original publication

DOI

10.2174/1389201021666201020162158

Type

Journal article

Journal

Current Pharmaceutical Biotechnology

Publisher

Bentham Science Publishers Ltd.

Publication Date

17/06/2021

Volume

22

Pages

1254 - 1263